CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ (36,129)	$ (68,093)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Equity in (earnings) losses of unconsolidated ventures	4,629	12,724
Depreciation and amortization	38,361	56,314
Impairment loss	10,146	5,239
Amortization of below market debt	1,497	1,453
Straight-line rental income, net and amortization of lease inducements	(428)	876
Amortization of premium/accretion of discount on investments	(55)	(49)
Amortization of deferred financing costs	909	1,024
Amortization of equity-based compensation	91	84
Realized (gain) loss on investments and other	(5,722)	(3,495)
Allowance for uncollectible accounts	460	585
Changes in assets and liabilities:
Receivables	53	2,772
Other assets	48	2,329
Due to related party	2,967	6,884
Escrow deposits payable	35	969
Accounts payable and accrued expenses	(7,548)	(6,952)
Other liabilities	(836)	598
Net cash provided by (used in) operating activities	8,478	13,262
Cash flows from investing activities:
Improvement of operating real estate investments	(8,158)	(13,732)
Sale of operating real estate	19,618	0
Sale of healthcare-related securities	0	35,771
Investment in unconsolidated ventures	(39,801)	(4,470)
Distributions from unconsolidated ventures	12,079	6,325
Other assets	583	0
Net cash provided by (used in) investing activities	(15,679)	23,894
Cash flows from financing activities:
Repayment of mortgage notes	(27,865)	(8,105)
Payment of deferred financing costs	0	(284)
Shares redeemed for cash	(5,182)	(16,073)
Payments under finance leases	(284)
Payments under finance leases		(294)
Distributions paid on common stock	(10,813)	(36,822)
Proceeds from distribution reinvestment plan	4,876	18,690
Contributions from non-controlling interests	318	289
Distributions to non-controlling interests	(139)	(310)
Net cash provided by (used in) financing activities	(39,089)	(42,909)
Net increase (decrease) in cash, cash equivalents and restricted cash	(46,290)	(5,753)
Cash, cash equivalents and restricted cash-beginning of period	94,508	80,488
Cash, cash equivalents and restricted cash-end of period	48,218	74,735
Supplemental disclosure of non-cash investing and financing activities:
Accrued distribution payable	0	5,192
Accrued capital expenditures	609	623
Reclassification of assets held for sale	0	14,423
Issuance of common stock as payment for asset management fees	5,000	5,000
Deconsolidation of securitization trust (VIE asset/liability)	0	512,772
Acquisition of operating real estate under capital lease obligations	$ 0	$ 1,921